Latent Viruses Cause Disease; CBCD Explains

Many scientists believe that latent viruses can only cause disease if reactivated. This is simply untrue.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Rochester, New York (PRWEB) June 13, 2012

The Center for the Biology of Chronic Disease (CBCD) has learned that Medpagetoday.com has published a story regarding the reactivation of latent viruses. The story focuses on the ability of the latent Epstein Barr virus (EBV) to reactivate and begin replicating itself…which in turn can spark inflammation in Multiple Sclerosis.

Many scientists believe that latent viruses can only cause disease if reactivated. Reactivation means that the virus begins to produce all of its proteins and make copies of itself on a large scale. In contrast, Dr. Polansky’s discovery says that viruses can cause disease while still latent, that is, without being reactivated.

The Theory of Microcompetition, as put forward by Dr. Hanan Polansky in his highly acclaimed “Purple Book” entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease,” explains how latent viruses can cause many major diseases. One of these viruses is the Epstein Barr virus, and one of these diseases is cancer.

Why is this important? Because most people who have an EBV infection do not know it. They harbor a latent infection that shows no symptoms, which are associated with reactivation. These people should be careful. They are at risk of developing cancer even if they don’t see the usual EBV symptoms.

Latent viruses replicate on a small scale even when they are not reactivated. This is something overlooked by many in the medical field today. As stated by Dr. Hanan Polansky, the latent EBV virus microcompetes with human genes for limited genetic resources, and as a result, can drive the human genes to malfunction, and cause disease.

Some scientists wrongly believe that if a virus is latent, then it is harmless. A latent virus is not dead. It continues to express some of its proteins and therefore to microcompete with human genes.

Consider the paper entitled “Human Cytomegalovirus Persistence” published February 13, 2012 in the journal, Cellular Microbiology. [1]

“Both the chronic and latent states of infection contribute to HCMV persistence and to the high HCMV seroprevalence worldwide. The chronic infection is poorly defined molecularly, but clinically manifests as low-level virus shedding over extended periods of time and often in the absence of symptoms.”

A virus is still shedding copies of itself during the latent phase, meaning it still replicates, and still microcompetes.

The same paper goes on to say: “Transcripts and proteins encoded from a region encompassing the major immediate early region are detected in hematopoietic cells following infection in vitro as well as in latently infected individuals.” (Kondo et al., 1996; Landini et al., 2000).

What does it all mean? Latent viruses such as the Epstein Barr virus continue to replicate, and therefore can cause disease even without reactivation, or while still latent.

Listen to Dr. Polansky describing his discovery during a recent interview by clicking on the following link.

http://dl.dropbox.com/u/41576890/02.06.12%20HHH%20Polansky%20Interview%20.mp3

“The key to your health is to reduce the level of latent viruses in your body to harmless levels.” – Dr. Hanan Polansky

So how does one reduce latent EBV?

It’s not easy. There are two traditional ways to attack the latent EBV virus: through vaccines and through antiviral medications. A vaccine is still in the early stages of development, and “There are…no regulatory agency-approved treatments for EBV-related diseases,” according to a study published in the Journal of Antimicrobial Chemotherapy. [2]

This means that currently there are no vaccines or drugs on the market to combat the active virus, let alone the latent virus.

However, the CBCD would like to point out a natural product designed to target the latent form of the virus. The name of that natural product is Gene-Eden-VIR. The CBCD encourages people infected with latent EBV to learn more about Gene-Eden-VIR.

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with one of our researchers, please visit http://www.cbcd.net or call 585-250-9999.

References:

[1] Goodrum F, Caviness K, Zagallo P. “Human Cytomegalovirus Persistence”, Cellular Microbiology, May 14, 2012

[2 Gershburg E., Pagano Joseph S., “Epstein Barr Virus Infections: Prospects for Treatment”, Journal of Antimicrobial Chemotherapy, 2005

http://jac.oxfordjournals.org/content/56/2/277.full

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

We invite biologists, virologists, scientists everywhere to download Dr. Polansky’s book, “Microcompetition with Foreign DNA and the Origin of Chronic Disease” here: http://cbcd.net/
The CBCD published the “Purple” book by Dr. Hanan Polansky.

The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.


Contact

  • John S. Boyd, PhD
    CENTER FOR THE BIOLOGY OF CHRONIC DISEASE
    (585) 250-9999
    Email

Attachments